Related Experiment Video

Updated: Aug 25, 2026

A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene
07:00

A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene

Published on: April 1, 2019

Thrombospondin gene polymorphisms and the risk of angiographic coronary in-stent restenosis

Saskia Z H Rittersma, S Matthijs Boekholdt, Karel T Koch

    The American Journal of Medicine
    |March 30, 2004
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
    04:30

    A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

    Published on: May 14, 2013

    Related Experiment Videos

    Last Updated: Aug 25, 2026

    A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene
    07:00

    A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene

    Published on: April 1, 2019

    A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
    04:30

    A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

    Published on: May 14, 2013

    Related Concept Videos

    Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

    Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

    Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...

    Articles linked to this work by shared authors, journal, and citation graph.

    Impact of Extent of Coronary Artery Disease in Transcatheter Aortic Valve Replacement: A PRO-TAVI Substudy.

    JACC. Cardiovascular interventions·2026

    Deferral of percutaneous coronary intervention in patients undergoing transcatheter aortic valve implantation (PRO-TAVI): an investigator-initiated, multicentre, open-label, non-inferiority, randomised controlled trial.

    Lancet (London, England)·2026

    Complex all-comers and patients with diabetes and prediabetes treated with Xience Sierra everolimus-eluting stents: COASTLINE high-risk.

    European heart journal open·2025

    VARC-HBR criteria validation in TAVI patients on oral anticoagulation.

    EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·2025

    Impact of diabetes on three-year outcome after coronary stenting in patients with polyvascular atherosclerotic disease - a secondary analysis of the randomized TWENTE trials.

    International journal of cardiology. Heart & vasculature·2025

    Elderly patients treated with Onyx versus Orsiro drug-eluting coronary stents in a randomized clinical trial with long-term follow-up.

    Clinical research in cardiology : official journal of the German Cardiac Society·2025

    Divergent Cardiac and Renal Outcomes by Systolic Blood Pressure in HFrEF.

    The American journal of medicine·2026

    Microplastics and Nanoplastics as a Novel Cardiovascular Risk Factor: A Narrative Review.

    The American journal of medicine·2026

    The Digital Incidentaloma Appreciating and Managing the Hazards of Continuous Digital Monitoring.

    The American journal of medicine·2026

    Trends in risk of subsequent fracture and post-fracture treatment among post-menopausal US women.

    The American journal of medicine·2026

    Cardiac Deceleration Capacity Refines Sudden Cardiac Death Risk Stratification in Patients with Hypertrophic Cardiomyopathy for Primary Prevention.

    The American journal of medicine·2026

    Herpes Zoster as a Trigger of Cardiovascular Events: A Systematic Review of Epidemiological Evidence and Pathophysiological Mechanisms.

    The American journal of medicine·2026

    Conservative management of a retained bullet in the right atrioventricular groove following a penetrating thoracic gunshot wound: a case report.

    AME case reports·2026

    Latent Class Analysis for Clustering Iranian Individuals Based on Cardiovascular Risk Factors.

    Medical journal of the Islamic Republic of Iran·2026

    Circadian mechanisms in heart failure: Cell-specific regulation and chrono-medicine.

    Cell insight·2026

    Vascular Phenotyping with Photoacoustic and Ultrasound Imaging in Cardiovascular Disease: Recent Innovations.

    Current treatment options in cardiovascular medicine·2026

    Aortic coarctation and McArdle disease in histiocytosis-lymphadenopathy plus syndrome: expanding the SLC29A3 spectrum.

    JCEM case reports·2026

    Comparison of hybrid coronary revascularization and minimally invasive multivessel CABG for multivessel coronary artery disease.

    Frontiers in cardiovascular medicine·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us